Rodriguez Raul R

CEO, President, DirectorRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Feb 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$60K
Net Open-Market Flow
-$60K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2024Sell(S)31K$1.14$35K2.0M
Feb 2, 2024Sell(S)22K$1.13$25K2.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-000445) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.